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This study examined the functional consequences of mutations in the gene for
rhodopsin. Electroretinograms (ERGs) were recorded from a transgenic mouse line
(VPP) with three mutations in the murine rhodopsin gene (V20G, P23H, P27L) that
cause a gradual photoreceptor degeneration. Stimulus conditions were chosen to allow
direct comparison to the form of autosomal dominant retinitis pigmentosa (ADRP) due
to the replacement of proline by histidine at position 23 (P23H).
Rod ERGs recorded from VPP mice showed an age-related amplitude
reduction and had prolonged implicit times. In comparison, cone ERGs of VPP mice
retained normal amplitudes up to 5 months of age; cone ERG implicit times were
prolonged at all ages. The time course of rod ERG amplitude recovery during dark
adaptation was slower in VPP mice than in normal littermates. These results are similar
to those reported for the human condition. Therefore, the VPP transgenic mouse line
appears to provide a valid model of the P23H form of human ADRP.
Finally, mice were raised in darkness to determine if light activation of
rhodopsin speeds the rate of degeneration. In comparison to cyclic-light reared mice,
dark-reared mice had ERGs that were larger in amplitude. However, these responses
were not normal, indicating that mechanisms other than light activation contribute to the
observed degeneration.
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CHAPTER I
INTRODUCTION
Retinitis Pi~mentosa (Rf)
Retinitis pigmentosa (RP) comprises a group of hereditary retinal degenerative
diseases characterized by progressive photoreceptor cell degeneration and eventual loss
of vision (Heckenlively et al., 1988). In the United States, RP has a prevalence of
about 1 in 4000 (Bunker et al., 1984; Berson, 1993), and an estimated 1.5 million
people are affected around the world (Berson, 1993). The initial symptoms of RP are
night blindness and visual loss in the mid peripheral visual field. As the condition
progresses, vision in the far peripheral field is decreased as is central vision. Patients
can have a normal fundus appearance in the early stages. At more advanced stages,
patient's signs include attenuated retinal vessels, intraretinal pigment, waxy pallor of
optic discs, cataracts (Heckenlively, 1982), and cystoid macular edema (Fetkenhour et
al., 1977; Fishman et al., 1977). The intraretinal pigment is distributed around the
mid-periphery at the zone of maximum concentration of rod cells. From a diagnostic
point of view, the hallmarks of RP are decreased rod sensitivity, progressive loss of
the electroretinographic response to light and characteristic pigmented deposits in the
retina.
Each of the three major transmission modes have been identified in RP:
autosomal dominant, autosomal recessive and X-linked. The frequency of families by
genetic type has been estimated to be 19% dominant, 19% recessive, 8% X-linked,
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46% isolates and 8% undetermined (Bunker et al., 1984). There is extensive
heterogeneity within each pattern of transmission. Therefore, it is likely that RP is a
group of diseases caused by gene abnormalities on several chromosomes.
Since RP is transmitted genetically, much attention has been paid to
identifying the molecular defects responsible. Using linkage analysis, McWilliam et
al. (1989) mapped the gene for autosomal dominant RP (ADRP) to the long arm of
chromosome 3, which includes the gene for rhodopsin. Recently, some patients with
ADRP were found to carry point mutations in the gene encoding rhodopsin (e.g., Dryja
et al., 1990; Fishman et al., 1991; Sung et al., 1991; Dryja, 1992; Fishman et al.,
1992; Berson, 1993; Sullivan et al., 1993). The mutations cosegregate with RP and
are not seen in unaffected relatives. At present, more than 40 mutations in the human
opsin gene have been linked to ADRP (Berson, 1993). In addition, defects in other
genes have been shown to cause RP. For example, RP is caused by mutations in the
genes for peripherin (a structural protein of rod and cone outer segments; Kajiwara et
al., 1991; Ferrar et al., 1992; Stone et al., 1993), and the B-subunit of rod
phosphodiesterase (McLaughlin et al., 1993).
Transc;enic Mouse Models of Human RP
Animal models have been widely used to understand the mechanisms
underlying retinal degeneration. Molecular genetics provides a means to introduce
specific genetic mutations into an otherwise normal genome. For ADRP, several
transgenic mice lines have been developed (Olsson et al., 1992; Chen et al., 1993;
Naash et al., 1993a,b). Olsson et al. (1992) created three transgenic lines from human
rhodopsin obtained from a normal or a patient with ADRP due to the replacement of

proline by histidine mutation at position 23 (P23H). The three lines containing the
mutant gene exhibited a photoreceptor degeneration which was very rapid and thus
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uncharacteristic of this form of human ADRP. Since lines expressing normal human
rhodopsin also showed a very rapid degeneration, this indicated that this was not an
accurate model of human ADRP due to a P23H mutation. Naash et al. (1993 a, b)
created a transgenic mouse line (VPP) that expresses a mutant murine rhodopsin under
the control of the endogeneous murine promoter. The mutant gene was identical to the
endogenous murine gene except for three point mutations at position 20, 23 and 27
along the rhodopsin molecule (V20G, P23H and P27L). Expression of the mutant
opsin transgene occurs simultaneously with the wild-type opsin gene.

As a

consequence, mice positive for the transgene exhibit a slowly progressive
photoreceptor degeneration of rod and cone cells. The P23H mutation was chosen
since this accounts for a large number of ADRP pedigrees (Dryja et al., 1990; Sung et
al., 1991; Berson et al., 1991). In fact, P23 is highly conserved in all sequenced
vertebrate and invertebrate opsin as well as related G protein coupled receptors
(Applebury and Hargrave, 1986).
Electroretino~ram

CERG)

The electroretinogram (ERG) represents the mass response of the retina to
light.

Since the ERG can be recorded from the corneal surface, it provides a

convenient, noninvasive method to monitor retinal function. As a result, the ERG is
widely used as a clinical test to diagnose abnormalities in retinal function (e.g.
Heckenlively et al., 1988).
Because recordings tend to be relatively stable for long periods of time, ERG
potentials can be studied quantitatively under a wide variety of conditions. When
elicited with a bright stimulus, the ERG is a complex potential with several major
components. An initial corneal negative potential, the a-wave, precedes the other
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waveforms. The a-wave represents the closure of Na+ ion channels along the rod
outer segment due to phototransduction (Penn and Hagins, 1969; Hood and Birch,
1990). The b-wave represents the Mtiller cell response to bipolar cell activity (Miller
and Dowling, 1970; Newman and Odette, 1984). In addition, other ERG potentials
can be detected under various conditions. For example, high frequency oscillatory
potentials are seen superimposed on the b-wave which appear to be separate from the
b-wave and may be due to amacrine cells (Dowling, 1987). In summary, careful ERG
analysis allows the activity of many neurons to be evaluated.
In the present study, the ERG has been used to provide an analysis of retinal
function in the VPP mice. In order to determine whether the VPP mouse line is a valid
model of human ADRP, it would be of value to have additional information with which
to compare the mouse model to the human condition. We have examined several
functional consequences of these mutations by recording ERGs under specific
conditions of adaptation. Patients with the P23H rhodopsin mutation can have a
relative initial sparing of the cone ERG (Dryja et al., 1990; Berson et al., 1991), and
there is a delay in the recovery of rod sensitivity during dark adaptation (Kemp et al.,
1992). Therefore, we compared rod- and cone-mediated ERGs obtained from VPP
mice at different ages (Experiment 1) and examined the time course of recovery of rod
ERG amplitude during dark adaptation following exposure to an adapting field
(Experiment 2).
In addition, the possibility that the time couse of retinal degeneration could be
altered by changing the degree of light exposure was assessed. Although previous
studies have found no beneficial effect of light deprivation for human patients with
ADRP (Berson, 1980; La Vail, 1980; Noell, 1980; Rapp and Williams, 1980), the
molecular defect for these patients was not known. Since rhodopsin is a light-activated
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protein, it seems possible that decreasing rhodopsin activity by limiting light exposure
may slow the time course of degeneration in the VPP mice. This possibility is
examined in Experiment 3.

CHAPTER II
MA1ERIALS and METHODS
Irans~enic

Mouse CVPP line)

The construction of the transgene has been described (Naash et al., 1993 a,
b). Briefly, the transgene was constructed by oligonucleotide-directed mutagenesis and
insertion of a mutated fragment into lambdaMOl containing the complete murine opsine
gene (Al-Ubaidi et al., 1990, Naash et al., 1993 a, b). The final transgene consisted of
a 15 kb mouse opsin genomic fragment which contained 6 kb upstream and 3.5 kb
downstream sequences, and in which a part of the wild type exon 1 of the opsin gene
was replaced by a fragment containing the mutations (Naash et al., 1993 a).
Transgenic mice pass the transgene to the offspring at 50% transmittance (Mendelian
inheritance). The transgene mice can be identified by PCR amplification of exon 1 with
primers W75/Wll, followed by digestion with NCOl. Wild-type mice (C57BU6 line)
exhibit three fragments of 689 bp, 431 bp and 197 bp. Heterozygous transgenic mice
have an additional fragment of 689 bp + 197 bp, due to the deletion of the NCOl site
(Naash et al., 1993 a, b).
Anesthesia and General Preparation
To record ERGs, mice were anesthetized with ketamine (10 mg), xylazine (4
mg) and urethane (400 mg) diluted with saline to a total volume of 10 ml.
Approximately 15 µl of this mixture was administered intramuscularly per gram of
body weight The pupil was dilated with 2.5% phenylephrine hydrochloride and the
6
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cornea was anesthetized with 0.5% proparacaine hydrochloride. Mice were placed on a
3goc heating pad throughout the experimental session.
ERG Recordin~ System
ERGs were recorded using an insulated 0.5 mm diameter stainless steel wire,
the end of which was stripped and coiled into an approximately 2 mm diameter circle.
This electrode made contact with the corneal surface through a layer of 1%
methylcellulose. A reference electrode was similarly prepared and placed in the mouth
and a needle electrode placed in the tail served as ground.

Responses were

differentially amplified (1 to 1000 Hz), averaged, and stored using a Nicolet Pathfinder
II signal averaging system. Strobe flash stimuli were presented in a Nicolet ganzfeld
(GS-2000), either in the dark or superimposed upon an adapting field. Stimuli were
either white (xenon) or blue (wratten filters 47, 47 A and 47B in combination). Flash
and adapting field luminances were calibrated with an EG&G model 550 photometer
equipped with a flash integrator for the calibration of strobe flashes.
Procedure
ERGs were obtained in two types of sessions. In one type of session, used in
Experiments 1 and 3, luminance-response functions were obtained under dark-adapted
and/or light-adapted conditions, to obtain rod-mediated and cone-mediated responses,
respectively. After an overnight period of dark adaptation, mice were prepared as
described above. A dark-adapted luminance-response function was then obtained
using 13 white flash luminances ranging between -3.13 and 0.85 log cd sec/m2. The
responses to two or three successive flashes were averaged. A 30 second interflash
interval was used for the five lowest luminance flashes, and 1 minute interval was used
for the 8 higher luminance flashes. Stimuli were presented in order of increasing
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luminance. In view of the predominance of rods in the mouse retina (Carter-Dawson
and Lavail, 1979 a, b), ERGs obtained under dark-adapted conditions are primarily
rod-mediated, although cones contribute somewhat to this response. Following this, a
1.60 log cdfm2 rod-desensitizing adapting field was presented. After waiting 10
minutes for the response to stabilize (Peachey et al., 1993), a light-adapted luminanceresponse function was obtained using 6 flash luminances ranging from -0.23 to 0.85
log cd sec/m2. Responses to 50-100 successive flashes presented at a rate of 2.3 Hz
were averaged together. Flash luminances were presented in increasing order. Based
on several criteria (Peachey et al., 1993), responses obtained under these conditions are
exclusively cone-mediated.
In Experiment 2, a second type of session was used to monitor the time couse

of ERG amplitude recovery during dark adaptation following exposure to an adapting
field. Baseline ERGs were collected to a standard blue flash (-2.12 log cd sec/m2).
Following this, a 2.4 log cdfm2 adapting field was presented for 3 minutes. After the
adapting field had been turned off, ERGs were obtained to the standard flash as a
function of time following adapting field termination. This continued until ERG bwave amplitude had returned to the baseline or the mouse awoke from anesthesia.
The amplitude of the a-wave was measured from the prestimulus baseline to
the trough of the a-wave. The amplitude of the b-wave was measured to the positive
peak, either from the trough of the a-wave or from the baseline when a-wave was not
presented. Implicit times were measured from the time of flash presentation to the awave trough or the b-wave peak. Experiments were blind to the presence or absence of
the transgene.

CHAPTER III
RESULTS
EJ\P«riment 1. - Time Course of Rod and Cone Dei:eneration
Figure 1 presents typical ERGs obtained under dark- and light-adapted
conditions for a 2 month old normal mouse (top) and for VPP mice at several different
ages. As early as 1 month of age, there is a reduction in rod ERG amplitudes. This
response becomes progressively smaller at later ages. In comparison, the amplitude of
the cone ERG remains normal until about 5 months of age. However, even at ages
where response amplitudes were normal, the waveform of the cone ERG showed
reproducible changes, including an overall delay in response timing.
Figure 2 presents luminance-response functions for the dark-adapted a-wave.
In this figure, and those that follow, hatched areas represents the mean

± S.E.M. for

28 normal littermates. At the earliest time point tested (1 month), the VPP mouse awave response function was significantly reduced below normal (F(l,7) = 67.45,
p<0.0001, Sheffe follow-up test p<0.001; Fig. 2A). In fact, there was no overlap
between the normal range and the data obtained from 1 month old mice (not shown). In
addition, a-wave implicit times were not significant but slightly delayed (Fig. 2B). At
later ages, a-wave amplitudes progressively diminished while a-wave implicit times
remain at a prolonged level similar to that seen at 1 month. At 9 months of age, awaves were no longer clearly seen even at the highest flash luminance (Fig.1 ).
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Figure 1.
ERGs obtained from representative normal and VPP mice of
different ages to 0.85 log cd sec/m2 strobe flash stimuli presented to the dark-adapted
(left) and light-adapted (right) eye. Dashed lines indicate the time of flash presentation.
a: a-wave, b: b-wave,
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Figure 2.
Luminance-response functions for rod a-wave amplitude (A)
and implicit time (B). The pair of dashed lines indicate the± 1 S.E.M. for 28 normal
mice. Symbols indicate the average response of VPP mice tested at the ages indicated.
Error bars indicate ± 1 S.E.M.
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Figure 3 presents the corresponding b-wave luminance-response functions.
At 1 month, the b-wave functions obtained from VPP mice were significantly reduced
in amplitude below normal (F(l,12) = 41.49, p<0.0001, Sheffe follow-up test
p<0.001; Fig. 3A), and not significantly delayed in implicit time (Fig. 3B). At later
ages, b-wave amplitudes progressively decreased while b-wave implicit times remained
prolonged.
Figure 4 presents luminance-response functions for the cone ERG b-wave. In
comparison to the rod-mediated responses obtained in the dark, there was no difference
in cone ERG amplitude for mice aged between 1 and 5 months of age (Fig. 1 and Fig.
4A). Only at 7 and 9 months were significant reductions observed in cone ERG
amplitude (F(l,5) = 7.33, p<0.05, Sheffe follow-up test p<0.05). Cone ERG implicit
times were not significant but slightly delayed (Fig. 4B). These data demonstrate that
the VPP mutations affect the cone photoreceptors at a later stage than they affect the rod
photoreceptors.
Figure 5 compares the time courses by which the amplitude measures
decrease. Each measure is expressed as a presentage of the normal mean. Rod
responses were only 45-60 % of normal at 1 month of age and slowly declined at later
ages. Cone ERG b-waves remained stable up to 5 months of age before declining with
age.
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Figure 3.
Luminance-response functions for rod b-wave amplitude (A)
and implicit time (B). The pair of dashed lines indicate the ± 1 S.E.M. for 28 normal
mice. Symbols indicate the average response of VPP mice tested at the ages indicated.
Error bars indicate ± 1 S.E.M.
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Figure 4.
Luminance-response functions for cone b-wave amplitude (A)
and implicit time (B). The pair of dashed lines indicate the± 1 S.E.M. for 28 normal
mice. Symbols indicate the average response of VPP mice tested at the ages indicated.
Error bars indicate± 1 S.E.M.
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Figure 5.
Time course of decrease in relative (%) amplitude for rod- and
cone-mediated response measures.
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Experiment 2. - Time Course of Rod Dark Adaptation
In this experiment, we determined the time course by which dark adaptation
proceeds. Figure 6 presents the time course of dark adaptation of the rod ERG
measured after the termination of the adapting field. To minimize intersubject
differences in absolute amplitude, responses for each mouse are expressed as a
percentage of the average dark-adapted baseline for that mouse. For the normal mice
(open squares, n=6), approximately 25 to 30 minutes were required for b-wave
amplitude to return to the dark-adapted baseline following the termination of the
adapting field. In comparison, the time course of dark adaptation was delayed in the
four VPP mice in which a complete data set was obtained. In fact, no VPP mouse
achieved the dark-adapted response amplitude although dark adaptation was monitored
for as long as 2 hours.
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Figure 6.
Amplitude recovery during dark adaptation for rod b-wave
amplitude. Amplitudes obtained from each mouse were normalized to the average
baseline response obtained after overnight dark adaptation. Following termination of
the adapting field at time zero, response amplitudes grow with time in the dark. Open
squares represent average (± 1 S.E.M.) results obtained from 6 normal two-month old
mice. Symbols indicate results obtained from 4 two-month old VPP mice. Baseline
responses ranged from 407 to 538 µV for normal mice and from 271to441 µV for
VPPmice.
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Ex,periment 3. - De.pen<lence of Retinal Dei:eneration on Li&ht Histozy
In this experiment, pregnant mice were housed in a dark room. The newborns
were then maintained in the dark. At 2, 4 and 6 months of age, dark-adapted
luminance-responses were obtained from these mice (normal; n=9, VPP; n=8).
Figure 7 presents luminance-response functions for the dark-adapted a-wave.

As expected, responses for normal mice raised in the dark (not shown) were similar to
those from mice raised under cyclic lighting hatched area. However, as shown in
Figure 7A, VPP mice raised in the dark (open symbols) produced a significantly larger
a-wave than did cyclic-light reared VPP mice (filled symbols). This difference was
significant at 2 months (F(l,130) = 30.23, p<0.0001, Sheffe follow-up test p<0.001)
and 4 months (F(l,102) = 48.22, p<0.0001, Sheffe follow-up test p<0.001). At 6
months of age, there was no significant difference between cyclic-light-reared and
dark-reared animals. However, relatively few animals have been tested at this age so
far. Similar differences between cyclic-light and dark-reared VPP mice were seen in
the b-wave (Fig. 8). These results suggest that light acts to accelerate the retinal
degeneration.
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Figure 7.
Luminance-response functions for rod a-wave amplitude (A)
and implicit time (B) to compare dark reared mice with mice of Experiment 1. The pair
of dashed lines indicate the ± 1 S.E.M. for 28 normal mice in Experiment 1. Symbols
indicate the average response of VPP mice and normal dark reared mice tested at the
ages indicated. Error bars indicate ± 1 S.E.M.
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Figure 8.
Luminance-response functions for rod b-wave amplitude (A)
and implicit time (B) to compare dark reared mice with mice of Experiment 1. The pair
of dashed lines indicate the± 1 S.E.M. for 28 normal mice in Experiment 1. Symbols
indicate the average response of VPP mice and normal dark reared mice tested at the
ages indicated. Error bars indicate ± 1 S.E.M. (A) VPP mice raised in the dark had
significantly larger amplitudes than cyclic-light-reared VPP mice at 2 months <F(l,216)
= 39.69, p<0.0001, Sheffe follow-up test p<0.001) and at 4 months (F(l,82) =
48.22, p=0.0001, Sheffe follow-up test p<0.001), but not at 6 months. (B) Implicit
time is not significant between dark reared and cyclic-light-reared VPP mice in 2, 4 and
6 months.
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CHAPTER IV
DISCUSSION
Swnmazy of Differences between Nonna! and YPP Mice
The ERG is an important test for the early diagnosis of RP in patients. In the
present study, the ERG has documented the functional consequences of mutations in
the murine rhodopsin gene. That the VPP mutations result in a slow degeneration of
the rod photoreceptors is demonstrated by the gradual reduction in the amplitude of the
dark-adapted rod a-wave response. This process is not confined to a simple decrease
in the number of photoreceptors, but also includes a delay in response timing.
The present results show that the VPP mutations selectively affect the rod
photoreceptors during the initial stages of the degeneration. As early as 1 month, there
is a clear reduction in the rod ERG a-wave, the amplitude of which continues to
decrease. In comparison, cone ERGs remain normal in amplitude up to about 5
months of age and only then begin to decrease in amplitude. Cone ERG implicit times
are prolonged somewhat at most ages tested. This observation indicates that cone
function is not completely normal, perhaps as a secondary effect of rod degeneration.
Histological analyses of the retina in normal and this mouse mutation mice
were reported by Naash et al. (1993 a). The results indicated that the outer segments
were formed at equivalent times during postnatal development. Before eye opening,
nascent outer segments were present in both normal and mutant mice. But after 8 days,
the outer segments of VPP mice were only 50% the normal length and continued to
29
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shorten.

This shortening was accompanied by a decrease in the number of

photoreceptors as reflected in a reduced thickness of outer nuclear layer (Naash et al.,
1993 a). These factors correspond, respectively, to the delayed and reduced rodmediated ERGs noted in the VPP mice (Figs. 1-3,5).
These results also show that the VPP mutations interfere with the mechanism
by which the rod system recovers sensitivity during dark adaptation following
exposure to an adapting field. Whereas normal mice had complete recovery within 25
min of dark adaptation, the VPP mice reguired at least 2 hours. There is an overall
similarity between this result and the prolonged time course of psychophysically
measured rod dark adaptation noted in patients with the P23H rhodopsin mutation
(Kemp et al., 1992). At present, the explanation for this delay is not known, although
several possibilities exist. The delay may reflect a defect in the processes underlying
the regeneration of rhodopsin. However, studies in patients with RP have shown that
rhodopsin regeneration proceeds at relatively normal rates (Highman and Weale, 1973;
Ripps et al., 1978), although the genotype of these patients is unknown. Alternatively,
a delay in dark adaptation may be caused by prolonged lifetimes of phototransduction
byproducts that desensitize the rods (Lamb, 1990). For example, phtoactivated
rhodopsin (R *) is normally deactivated by rhodopsin kinase and arrestin (Stryer,
1988). If the VPP mutations interfere with the interaction of these proteins with R*,
then this may cause the delay in dark adaptation. The VPP mutations may also interfere
with binding of 11-cis-retinaldehyde to rhodopsin. While these interactions occur at
regions within the membrane domain of the rhodopsin molecule (Franke et al., 1992),
they may be significantly modified by changes in the intradiscal regions of the molecule
(Khorana, 1992), including the N-terminus (Doi et al., 1990). Another possibility is
that the VPP mutant rhodopsin is not functional. In view of this, there is a range
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of possibilities by which a nonfunctional mutant rhodopsin may interfere with the
deactivation of normal R *.
Comparison between Human ADRP Patients and YPP Mice
Functionally, there are several points of similarity between the VPP mouse
and P23H form of human ADRP. In both cases, i) the retinal degenerations are
relatively slow; ii) the retinal degenerations are rod-specific at the initial stages; iii) the
retinal degenerations affect cone photoreceptors at the later stages of the disease; iv) the
retinal degenerations delay dark adaptation recovery. These similarities indicate that the
VPP mouse line may be a valid model of human ADRP.
It should be noted that there are 3 rhodopsin mutations in the VPP mice:
V200, P23H and P27L. While P23H appears to be responsible for some forms of
human ADRP (Berson et al., 1991; Dryja et al., 1991; Fishman et al., 1991; Kemp et
al., 1992), to date neither V200 nor P27L have been identified in patients with ADRP
(Berson, 1993). Therefore, it is most likely that the P23H mutation is primarily
responsible for the retinal degeneration seen in the VPP mice. Determining the role of
V200 and P27H mutations in the etiology of this retinal degeneration will require
development of a mouse line expressing these mutations in isolation.
Possibility of Alterine the Time Course of Disease Proeression
Protecting the VPP retina from light exposure slowed the rate of retinal
degeneration. This was shown by the retention of larger ERG amplitudes at each age
tested by VPP mice raised in the dark. This raises the possibility the human patients
with the P23H form of ADRP may benefit from decreasing levels of retinal
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illumination.

However, future studies are needed to replicate and extend this

observation.
Future Directions and Goals
Since the VPP mouse provides a valid model of RP, it is reasonable to
consider avenues for future research. For example, along the lines of treatment it
would be of value to consider the possibility that vitamin A may be of value. Berson et
al. (1993) recently reported a clinical trial in which vitamin A supplementation acted to
slow the rate of ERG amplitude loss in a heterogenous group of RP patients. In the
VPP mouse, it is possible that the mutant rhodopsin has a decreased affinity for retinal
derived from vitamin A. As a result the VPP rhodopsin mouse in an active form,
thereby interfering with normal cellular function. Increasing vitamin A could act to
quench this activity and contribute to cellular stability.
In this and other ways, the VPP model will be used in the future to understand

how disruption of the N-terminus region of the rhodopsin molecule results in a
progressive retinal degeneration.
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